BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: An undetermined target

May 12, 2016 7:00 AM UTC

Mouse studies suggest the ketamine metabolite (2R,6R)-hydroxynorketamine could help treat depression. In three mouse models of depression, the metabolite decreased depressive behaviors 24 hours after ...